Priyanka Shah

VP, Investor Relations & Communications at Kinnate Biopharma

Priyanka brings to Kinnate over 15 years of experience in leading and driving metrics-based end-to-end communications from conception through implementation for small and large publicly traded biotech/pharma and healthcare companies. Her deep knowledge and leadership span corporate, financial, and pipeline/product communications, as well as CSR/ESG, issues/crisis management, media relations, thought leadership, and enterprise engagement.

Most recently she served as the head of communications and CSR/ESG lead at Mirati Therapeutics, Inc., targeted oncology biotech. Previously, she held roles of increasing responsibility at Bristol Myers Squibb with leadership positions in Corporate and Worldwide Oncology Communications. Prior to this, she served as a senior, strategic communications advisor to healthcare (RX, DX, Consumer) clients while at mid-size to large public relations firms.

She earned a BA in Communications and Public Relations, and a MA in Communication & Information Studies with a focus on Organizational and Mediated Communications, both from Rutgers University.


  • VP, Investor Relations & Communications

    Current role

View in org chart